Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : qtrn(quintiles trans) -- Ignore unavailable to you. Want to Upgrade?

To: Graham who wrote (18)	3/24/1999 2:29:00 PM
From: Andrew Cooke	Read Replies (1) \| Respond to of 105

My thoughts are that the price drop is unwarranted - and much will change next week and in late April. Earnings are only 1 month out, and given QTRN's consistent qtrly performance, the stock will see a boost. The prospect of good earnings should hopefully cause the significant short position to unwind before the end of April as well, giving support to buyers. On YAHOO bd there are comments re: price summarized as follows: 1. end of qtr window-dressing by institutions; 2. dilution due to share exchange rate with ENVY shareholders; 3. fear of further dilution through a renegotiated deal w/ENVY due to QTRN price prior to merger closing; 4. deal not approved by ENVY shareholders b/c of QTRN price; 5. acquisition costs due to all of QTRN's acquisitions. This is a good company with a solid history; I will be surprised to see prices this low for very long. AC